A Theory-based Sleep Hygiene Education for Insomnia Disorder
A Theory-based Sleep Hygiene Education for Insomnia Disorder - A Non-inferiority Randomized Controlled Trial With Mixed-method Process Evaluation and Cost-effectiveness Analysis
調査の概要
詳細な説明
Insomnia is a prevalent sleep disorder associated with substantial adverse health consequences, including fatigue, irritability, and impaired daytime functioning. Although effective pharmacological (e.g., hypnotics) and psychological treatments (e.g., cognitive behavioral therapy for insomnia, CBT-I) are available, both local and international surveys indicate that fewer than 50% of individuals with insomnia seek treatment. This treatment gap underscores the need for effective non-pharmacological interventions that are both accessible and acceptable.
Sleep hygiene education (SHE) represents a potentially suitable approach to address this unmet need. SHE is an educational intervention encompassing a range of lifestyle and environmental recommendations to optimize sleep quality and duration. These include maintaining a regular sleep-wake schedule, avoiding substances such as caffeine, nicotine, and alcohol, limiting daytime napping and stimulating activities before bedtime, optimizing the sleep environment, and adopting appropriate dietary and exercise habits etc. Given its simplicity, low cost, accessibility, and ease of delivery and adoption, SHE holds promise as a non-pharmacological strategy for insomnia management.
Despite these advantages, SHE is not typically recommended as a stand-alone treatment for individuals with sleep problems, as it is often perceived to be less effective than CBT-I or mindfulness-based interventions, with consistently small effect sizes reported. However, these findings should be interpreted with caution. In many previous studies, SHE has primarily been used as a passive control condition to account for nonspecific treatment effects, thereby underexploiting its active therapeutic potential. Moving SHE beyond a simple advice-giving modality to a structured, theory-informed approach may optimize its effectiveness by ensuring its content is informative and promising. Integrating SHE with established behavior change techniques may better equip individuals with the skills needed to initiate and sustain meaningful behavioral change.
Building on our previously registered pilot-testing protocol, this study aims to evaluate the effectiveness of a theory-based SHE program integrated with behavior change techniques in a larger community sample. In addition, it remains unclear whether theory-based SHE is inferior to gold-standard interventions such as digitally delivered CBT-I. This study will also examine whether a theory-based SHE program is a cost-effective approach for reducing insomnia severity in adults with insomnia disorder compared with a CBT-I app and a no-intervention control. To address these objectives, a three-arm randomized controlled trial will be conducted to compare the relative effectiveness of these interventions.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Wing Fai YEUNG
- 電話番号:852-27664151
- メール:jerry-wf.yeung@polyu.edu.hk
研究場所
-
-
-
Hong Kong、香港
- School of Nursing, The Hong Kong Polytechnic University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Hong Kong residents
- Ethnic Chinese aged 18-65 years with the ability to communicate in Cantonese or Putonghua
- Who fulfil the DSM-5 diagnostic criteria for insomnia disorder according to a validated diagnostic tool, the Brief Insomnia Questionnaire
- Scored at least 10 points in the Insomnia Severity Index
- Willing to give informed consent
Exclusion Criteria:
- Any current diagnosis fulfilling the DSM-IV criteria of a major depressive disorder, generalized anxiety disorders, post-traumatic stress disorder, panic disorder, substance use disorders, or schizophrenia as screened using the Chinese version of the Structured Clinical Interview for DSM-IV
- Other sleep disorders, including circadian rhythm disorder, narcolepsy, obstructive sleep apnoea (OSA), and restless leg syndrome (RLS)/periodic leg movement disorder (PLMD) as determined based on cut-off scores (≥ 7 on narcolepsy; ≥ 8 on circadian rhythm disorder; ≥ 15 on OSA; ≥ 7 on RLS/PLMD) using SLEEP-50. If in doubt, subjects will be referred to our team psychiatrist (KF Chung) for further assessment
- Any current medical conditions or side-effects of medication that are contributing significantly to the subject's insomnia
- Taking medications or currently participating in other psychotherapies for insomnia or other psychiatric disorders
- Impaired cognitive functioning (<22 points in HK-MoCA) or with difficulty in giving consent or understanding instructions
- Pregnant
- Shift work
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Sleep Hygiene Education
Participants in this group will receive a structured six-week SHE intervention.
The intervention includes two weekly 2-hour group-based, face-to-face educational sessions (total 4 hours) conducted in a classroom at the School of Nursing, The Hong Kong Polytechnic University, followed by four weekly individualized telephone consultations lasting approximately 10 minutes each.
During the educational sessions, participants will receive education on insomnia and evidence-based sleep hygiene practices, and will develop individualized behavior change plans to support sustained implementation of sleep hygiene practices.
The subsequent telephone consultations will reinforce adherence to these plans by reviewing progress, discussing barriers, and providing tailored feedback.
|
Participants in this group will receive a structured six-week SHE intervention.
The intervention includes two weekly 2-hour group-based, face-to-face educational sessions (total 4 hours) conducted in a classroom at the School of Nursing, The Hong Kong Polytechnic University, followed by four weekly individualized telephone consultations lasting approximately 10 minutes each.
During the educational sessions, participants will receive education on insomnia and evidence-based sleep hygiene practices, and will develop individualized behavior change plans to support sustained implementation of sleep hygiene practices.
The subsequent telephone consultations will reinforce adherence to these plans by reviewing progress, discussing barriers, and providing tailored feedback.
|
|
アクティブコンパレータ:CBT-I App
Participants in this group will receive a CBT-I program consisting of six weekly modules delivered in the Chinese language through a smartphone application proACT-S.
The duration of each module is around 45 to 60 min with interactive features.
The self-help CBT-I treatment content in proACT-S is based on the Chinese translated version of a well-established CBT-I treatment manual.
The self-help CBT-I treatment content is designed to alter dysfunctional cognitive beliefs and maladaptive behaviors that perpetuate insomnia.
The self-help CBT-I treatment content CBT-I aims at changing dysfunctional cognitive beliefs and maladaptive behaviors that contribute to the maintenance of insomnia.
|
Participants in this group will receive a CBT-I program consisting of six weekly modules delivered in the Chinese language through a smartphone application proACT-S.
The duration of each module is around 45 to 60 min with interactive features.
The self-help CBT-I treatment content in proACT-S is based on the Chinese translated version of a well-established CBT-I treatment manual.
The self-help CBT-I treatment content is designed to alter dysfunctional cognitive beliefs and maladaptive behaviors that perpetuate insomnia.
The self-help CBT-I treatment content CBT-I aims at changing dysfunctional cognitive beliefs and maladaptive behaviors that contribute to the maintenance of insomnia.
|
|
介入なし:Waitlist Control
Participants in this group will receive no intervention from the study.
They will be provided with the same SHE program and CBT-I apps after the follow-up period.
Waitlist control is chosen as previous surveys have revealed that almost half of individuals with clinical insomnia refrain from seeking any treatment.
Therefore, the waitlist control group reflects the typical help-seeking behavior of those coping with insomnia, thus providing a more realistic comparison for our study.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The Insomnia Severity Index (ISI)
時間枠:Baseline, week 6, week 12 and week 24
|
The Insomnia Severity Index has 7 items that measured the severity of insomnia complaints and related daytime impairments.
The total score ranges between 0 and 28, with the higher scores indicating more severe insomnia.
Total score will be used.
|
Baseline, week 6, week 12 and week 24
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Sleep Onset Latency Measured By Sleep Diary
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Participants will be asked to record their daily sleeping-waking schedule using a standard sleep diary.
Sleep onset latency (SOL) is defined as the time (minutes) taken to fall asleep after going to bed.
The average value over 7 consecutive nights will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Wake After Sleep Onset Measured By Sleep Diary
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Participants will be asked to record their daily sleeping-waking schedule using a standard sleep diary.
Wake after sleep onset (WASO) is defined as the total time (minutes) awake after initial sleep onset during the night.
The average value over 7 consecutive nights will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Sleep Efficiency Measured By Sleep Diary
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Participants will be asked to record their daily sleeping-waking schedule using a standard sleep diary.
Sleep efficiency (SE) is defined as the percentage of time in bed spent asleep.
The average percentage over 7 consecutive nights will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Total Sleep Time Measured By Sleep Diary
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Participants will be asked to record their daily sleeping-waking schedule using a standard sleep diary.
Total sleep time (TST) is defined as the total duration (minutes) of sleep per night.
The average value over 7 consecutive nights will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
The Hospital Anxiety and Depression Scale (HADS)
時間枠:Baseline, week 6, week 12 and week 24
|
The Hospital Anxiety and Depression Scale is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
|
Baseline, week 6, week 12 and week 24
|
|
The Short-Form Six Dimensions (SF-6D)
時間枠:Baseline, week 6, week 12 and week 24
|
The Short-Form Six Dimensions (SF-6D) will be used to assess the quality of life.
The score ranges from 0 (worst quality of life) to 1 (perfect quality of life), with higher scores reflecting better overall health-related quality of life.
|
Baseline, week 6, week 12 and week 24
|
|
Sleep Onset Latency Measured By Actigraphy
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Sleep onset latency (SOL) will be objectively measured using a wrist-worn actigraphy device (GENEActiv, Activinsights, UK).
Participants will wear the device on their non-dominant wrist for 7 consecutive nights prior to each assessment time point.
SOL will be recorded in minutes, and the mean value over the 7-night period will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Wake After Sleep Onset Measured By Actigraphy
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Wake after sleep onset (WASO) will be objectively measured using a wrist-worn actigraphy device (GENEActiv, Activinsights, UK).
Participants will wear the device on their non-dominant wrist for 7 consecutive nights prior to each assessment time point.
WASO will be recorded in minutes, and the mean value over the 7-night period will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Sleep Efficiency Measured By Actigraphy
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Sleep efficiency (SE) will be objectively measured using a wrist-worn actigraphy device (GENEActiv, Activinsights, UK).
Participants will wear the device on their non-dominant wrist for 7 consecutive nights prior to each assessment time point.
SE will be expressed as a percentage, and the mean value over the 7-night period will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
|
Total Sleep Time Measured By Actigraphy
時間枠:7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
Total sleep time (TST) will be objectively measured using a wrist-worn actigraphy device (GENEActiv, Activinsights, UK).
Participants will wear the device on their non-dominant wrist for 7 consecutive nights prior to each assessment time point.
TST will be recorded in minutes, and the mean value over the 7-night period will be calculated.
|
7 consecutive nights before each assessment time point (i.e., baseline, week 6, week 12, and week 24)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- SHCI
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。